GlassScriptPhysician profile
David A Staneck
NPI 1730181199
$6,751.57
in general payments reported to CMS, 2019-2025
36 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what 95% of Aerospace Medicine providers received nationally (typical 2025 total: $89.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $290 · 2021: $544 · 2022: $1,039 · 2023: $2,233 · 2024: $852 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,534 · Travel and Lodging: $1,334 · Education: $238 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,533.63 |
| Travel and Lodging | $1,334.27 |
| Education | $237.98 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $975.28 | 2021-2024 | Urolift |
| Valencia Technologies Corporation | $880.41 | 2023 | Ecoin Device Kit |
| Pfizer INC. | $693.10 | 2019-2025 | |
| Astellas Pharma US INC | $597.99 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $393.18 | 2019-2025 | Axonics, Rezum Generator |
| Janssen Biotech, INC. | $384.87 | 2019-2025 | Erleada |
| Abbvie INC. | $352.39 | 2022-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $298.32 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $269.71 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $233.71 | 2019-2023 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $221.24 | 2021-2024 | Prolaris |
| Myovant Sciences INC. | $146.16 | 2021-2022 | |
| Travere Therapeutics, INC. | $146.01 | 2019-2022 | |
| Olympus America INC. | $106.69 | 2025 | Itind System |
| Accord Healthcare, INC. | $102.21 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $92.91 | 2019 | |
| Progenics Pharmaceuticals, INC. | $88.51 | 2024-2025 | |
| Convatec INC. | $82.48 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $81.24 | 2024-2025 | Lynparza |
| Endo USA, INC. | $78.35 | 2025 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $67.74 | 2025 | |
| Amgen INC. | $66.46 | 2022-2023 | Xgeva |
| 180 Medical, INC. | $55.77 | 2024-2025 | Cure Catheter |
| Blue Earth Diagnostics | $42.54 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $42.10 | 2024-2025 | |
| Antares Pharma, INC. | $38.39 | 2020 | |
| Axonics, INC. | $35.96 | 2023-2024 | Axonics, Bulkamid |
| Telix Pharmaceuticals | $29.63 | 2025 | Illuccix |
| Procept Biorobotics Corporation | $27.96 | 2024 | Aquabeam System |
| Novartis Pharmaceuticals Corporation | $20.19 | 2022 | |
| Verity Pharmaceuticals INC. | $18.64 | 2025 | Tlando |
| Tolmar Pharmaceuticals, INC. | $18.50 | 2019 | |
| Coloplast Corp | $16.61 | 2020 | |
| Immunitybio, INC. | $15.99 | 2024 | |
| Laborie Medical Technologies Corp. | $15.82 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $14.51 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Staneck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.